U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 463 records

Showing results for "renal".

  1. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
    November 07, 2023 - Expert #4 ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe renal … major decision maker in this section, or if it stays in, specify that the contraindication is severe renal … evidence summary does not include information on the potential contraindications of acamprosate (severe renal … should be careful to respect contraindications of each individual medication (for acamprosate, severe renal

  2. Treatment for Fetal Atrioventricular Block in Pregnant Individuals with Anti-SSA and Anti-SSB Antibodies (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fetal-treatment-key-questions.pdf
    January 01, 2023 - fetal harms such as congenital malformations, preterm birth, low birthweight; maternal harms such as renal

  3. Skin Substitutes for Treating Chronic Wounds (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
    October 03, 2019 - health requirements (e.g., status of HbA1c, diabetes, peripheral vascular disease, obesity, smoking, renal … and general health (e.g., status of HbA1c, diabetes, peripheral vascular disease, obesity, smoking, renal

  4. Ced -Appendix-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    October 12, 2022 - unless otherwise contraindicated for populations represented by Medicare, (e.g., seniors or patients in renal … unless otherwise contraindicated for populations represented by Medicare, (e.g., seniors or patients in renal

  5. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Toxicity was more likely with MTX in patients with greater renal impairment. … Those with high risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … Toxicity was more likely with MTX in patients with greater renal impairment. … New Evidence: Those with highrisk comorbidities (cardiovascular events, diabetes, malignancies, renal

  6. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Toxicity was more likely with MTX in patients with greater renal impairment. … Those with high risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … Toxicity was more likely with MTX in patients with greater renal impairment. … New Evidence: Those with highrisk comorbidities (cardiovascular events, diabetes, malignancies, renal

  7. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
    January 01, 2013 - Reticulocyte indices in patients with end stage renal disease on hemodialysis. … Contribution of iron deficiency to anemia in chronic renal failure. … to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal … Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. … With Chronic Kidney Disease Not yet recruiting Drug: Cholecalciferol 28 NCT01138241 Tenofovir Renal

  8. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
    May 14, 2010 - in December 2008 regarding the possible association of the use of pamidronate with deterioration of renal … Drug Labeling Change to Pamidronate (Aredia) Regarding Link to Renal Failure.

  9. Safety of Vaccines Used for Routine Immunization in the United States | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/safety-vaccines/protocol
    April 06, 2020 - transplantation: official publication of the European Dialysis and Transplant Association - European Renal … of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal … Renal failure. 2015;37(7):1080-8. Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders Pregnancy, puerperium and perinatal conditions Psychiatric disorders Renal

  10. Cad-Women-Treatment Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … effects of interventions: adverse drug reactions, radiation exposure, access site complications, renal … CABG can result in wound infections, renal dysfunction, and bleeding.

  11. Effectiveness of Isosorbide Dinitrate and Hydralazine in Racial/Ethnic Subgroups With Heart Failure | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/congestive-heart-failure-medicines/research
    March 31, 2010 - Clinically significant comorbidities were more frequent in the group receiving H-ISDN; for example, renal … 54 <.0001 Diabetes (complicated) 15.3% 27 <.0001 Hypothyroidism 5.1% 4.2 0.01 Renal

  12. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
    November 19, 2009 - For example, intact parathyroid hormone (PTH) measurements are used to manage patients with renal osteodystrophy … of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal

  13. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
    February 01, 2013 - No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage renal … No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically excluded … Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With RLS and End- Stage Renal … GEn 1200/6000mg; Placebo; Moxifloxacin NCT00422994 A Study To Investigate The Effects Of End Stage Renal

  14. Behavioral Programs for Diabetes Mellitus | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/research-protocol
    June 05, 2014 - glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal

  15. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
    November 24, 2014 - More information regarding patients’ baseline characteristics, particularly renal clearance, APACHE … results section, we have added more details when available on baseline characteristics, particularly renal … In the Results section we added data on baseline characteristics, particularly renal clearance, APACHE … , or antibiotic-related adverse events differ for subgroups defined by age, sex, race, ethnicity, renal

  16. Autism-Update Espanol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_espanol.pdf
    November 01, 2014 - vigilancia médica, estos productos pueden causar daños graves, entre ellos deshidratación, insuficiencia renal

  17. Tratamientos para los niños con trastorno del espectro autista | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/autism-update/espanol
    December 04, 2014 - vigilancia médica, estos productos pueden causar daños graves, entre ellos deshidratación, insuficiencia renal

  18. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment/research-protocol
    March 05, 2012 - systemic antibiotics (KQ 2) Allergic and hypersensitivity reactions Drug toxicity (not allergic) Major—renal … daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Table 3 Table 3.

  19. Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
    November 01, 2023 - Acamprosate is contraindicated in patients with severe renal impairment.

  20. Integrating Palliative Care in Ambulatory Care of Non-Cancer Serious Chronic Illness | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/palliative-care-integration/protocol
    January 10, 2020 - disease (Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria III or IV), end-stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end- stage renal
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites